"Myeloproliferative" Natural Recordings by Native Speakers
Myeloproliferative refers to a group of rare blood disorders characterized by the overproduction of blood cells, particularly white blood cells, red blood cells, or platelets. This can lead to an abnormal accumulation of these cells in the bone marrow and blood, potentially causing symptoms such as easy bruising, petechiae, and splenomegaly (enlargement of the spleen). Examples of myeloproliferative disorders include essential thrombocythemia, polycythemia vera, and primary myelofibrosis.
Here are 5 usage examples for the word "myeloproliferative":
Myelopathy is a medical term that refers to a condition in which there is damage to the spinal cord, which can be caused by a variety of factors such as injury, infection, or degenerative disease. It can result in a range of symptoms, including numbness, weakness, and paralysis of the arms and legs, as well as loss of bladder and bowel control. The term "myelopathy" is often used to describe a condition that affects the spinal cord directly, rather than the peripheral nerves.
Myelophthisis is a medical condition characterized by the replacement of bone marrow by cancerous or fibrous tissue, typically as a result of metastatic cancer or irradiation. It can lead to anemia, leukemia, or other blood disorders due to the diminishment or loss of normal bone marrow function. Myelophthisis can occur in various parts of the skeleton, but it most commonly affects the vertebrae, ribs, and sternum.
Myelopoiesis refers to the process by which myeloid stem cells mature into different types of blood cells, such as red blood cells, white blood cells, and platelets. This process occurs in the bone marrow and is crucial for the development and maintenance of a healthy blood system.
Relating to the formation or development of myeloid cells, such as white blood cells, red blood cells, and platelets, in the bone marrow.
Myelorrhaphy is a surgical procedure that involves the suturing or repair of the spinal cord or spinal nerves. It is typically performed to treat injuries or conditions that have damaged the spinal cord or nerves, such as herniated discs, spinal fractures, or spinal cord injuries. The goal of myelorrhaphy is to alleviate pain, restore function, and improve quality of life for individuals with spinal cord injuries or conditions.
Myelosarcoma is a type of cancer that originates in the bone marrow and affects the blood-forming cells. This rare type of cancer is characterized by the uncontrolled growth of abnormal cells in the bone marrow, which can lead to an abnormal production of blood cells. Myelosarcoma can present with various symptoms, including fatigue, weakness, bleeding, and anemia, and may require a combination of chemotherapy, radiation therapy, and bone marrow transplantation for treatment.
Myelosuppressive refers to a substance or treatment that reduces the production of new blood cells in the bone marrow, particularly the red and white blood cells. It can also refer to a condition or disease that suppresses the bone marrow's ability to produce blood cells, often as a result of chemotherapy, radiation therapy, or other medical treatments.
Myelotomy refers to a surgical incision made into the spinal cord or spinal membranes to relieve compression or blockage of the spinal cord, often caused by tumors, herniated discs, or other conditions. The goal of myelotomy is to decompress the spinal cord, reduce pressure, and alleviate symptoms such as numbness, weakness, or paralysis.
Myelotoxicity refers to the ability of a substance, such as a medication or radiation, to cause damage to the myeloid cells in the bone marrow, which are responsible for producing red and white blood cells and platelets. This can lead to a deficiency in these cells, resulting in conditions such as anemia, neutropenia (a decrease in white blood cells), and thrombocytopenia (a decrease in platelets).